CRISPR Therapeutics CRSP Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies

GATXGATX

$1.75M+243%

SeaboardSEB

$0-100%

RepligenRGEN

-$145K-104%

FTI ConsultingFCN

-$4.67M-179%

Skyline ChampionSKY

$2.75M+135%

ConstelliumCSTM

-$2M-150%

Other financials

Income statement

See full

Revenue$1.5M+68.6%

Operating income-$130.2M+12.2%

Net income-$122.9M+9.6%

EPS (diluted)-$1.28+19.0%

Balance sheet

See full

Cash & equivalents$423.3M+80.0%

Total debt$787.6M+259%

Total equity$1.8B-0.8%

Total assets$2.7B+25.8%

Cash flow

See full

Operating cash flow-$108.9M-102%

CapEx$504.0K+145%

Free cash flow-$109.4M-102%

Valuation

See full

Market cap$5.33B+56.4%

Enterprise value$5.69B+69.8%

P/S1,298.3×+1,208×

Profitability

See full

Operating margin-15,754.2%-17,253pp

Net margin-13,856.5%-15,058pp

FCF margin-9,777.6%-10,759pp

Returns & leverage

See full

Return on equity-31.2%+43.7pp

Debt / equity0.4×+0.3×

Current ratio18×+2.3×

Where this comes from

Reported directly by CRISPR Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CRISPR Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?: CRISPR Therapeutics (CRSP) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of -$32K in Q1 2026.
How has CRISPR Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?: CRISPR Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash decreased by 178.0% year-over-year, from $41K to -$32K.